Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;6(4):495-507.
doi: 10.15171/apb.2016.063. Epub 2016 Dec 22.

Overview of Albumin and Its Purification Methods

Ramin Raoufinia  1 , Ali Mota  2 , Neda Keyhanvar  3 , Fatemeh Safari  3 , Sara Shamekhi  3 , Jalal Abdolalizadeh  4
Affiliations
Review

Overview of Albumin and Its Purification Methods

Ramin Raoufinia et al. Adv Pharm Bull. 2016 Dec.

Abstract

As the most frequent plasma protein, albumin constitutes more than 50% of the serum proteins in healthy individuals. It has a key role in oncotic pressure maintenance and it is known as a versatile protein carrier for transportation of various endogenous and exogenous ligands. Reduced amounts of albumin in the body will lead to different kinds of diseases such as hypovolemia and hypoproteinemia. It also has various indications in shocks, burns, cardiopulmonary bypass, acute liver failure and etc. Further applications in research consist of cell culture supplement, drug delivery carrier and protein/drug stabilizer. So, the demand for albumin increased annually worldwide. Due to different applications of albumin, many efforts have been accomplished to achieve albumin during a long period of time. In this review, an overview of serum albumin and different purification methods are summarized.

Keywords: Chromatography; Human serum albumin; Immunoaffinity; Purification.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Figure 4
Figure 4
See this image and copyright information in PMC

References

    1. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: From bench to bedside. Mol Aspects Med. 2012;33(3):209–90. doi: 10.1016/j.mam.2011.12.002. - DOI - PubMed
    1. Chen Z, He Y, Shi B, Yang D. Human serum albumin from recombinant DNA technology: Challenges and strategies. Biochim Biophys Acta. 2013;1830(12):5515–25. doi: 10.1016/j.bbagen.2013.04.037. - DOI - PubMed
    1. Ascenzi P, Fasano M. Allostery in a monomeric protein: The case of human serum albumin. Biophys Chem. 2010;148(1-3):16–22. doi: 10.1016/j.bpc.2010.03.001. - DOI - PubMed
    1. Hirose M, Tachibana A, Tanabe T. Recombinant human serum albumin hydrogel as a novel drug delivery vehicle. Mater Sci Eng C. 2010;30(5):664–9. doi: 10.1016/j.msec.2010.02.020. - DOI
    1. Curry S. Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metab Pharmacokinet. 2009;24(4):342–57. doi: 10.2133/dmpk.24.342. - DOI - PubMed